XASX
BLG
Market cap18mUSD
Oct 09, Last price
0.20AUD
1D
0.00%
1Q
-41.18%
Jan 2017
-28.57%
IPO
-48.72%
Name
BluGlass Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BluGlass Limited, along with its affiliated entities, is dedicated to advancing semiconductor manufacturing technologies and creating innovative devices. Their offerings cater to various demanding sectors, including industrial, defense, display, and scientific markets across Australia and the United States. A cornerstone of their operations is the development and commercialization of their patented remote plasma chemical vapor deposition (RPCVD) technology. This low-temperature method is specifically designed to produce high-performance gallium nitride laser diodes. Furthermore, BluGlass provides expert foundry services. The company was established in 2005 and is based in Silverwater, Australia.
Key people
Omer Granit
Executive Chairman of the Board · since 2025
Samuel Samhan
Chief Financial Officer · since 2023
Ian Mann
Chief Operations & Technology Officer · since 2020
Brad Siskavich
Executive Vice President
James Haden
Chief Executive Officer, Executive Director · since 2025
Executive Chairman of the Board · since 2021
Andrew Palfreyman
Joint Company Secretary · since 2026
Patricia Vanni
Company Secretary · since 2024
Ata Gokyildirim
Non-Executive Independent Director · since 2025
Non-Executive Independent Director · since 2018
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||